JAK2 V617F Hematopoietic Clones Are Present Several Years Prior to MPN Diagnosis and Follow Different Expansion Kinetics

Blood advances - United States
doi 10.1182/bloodadvances.2017007047
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

American Society of Hematology

Related search

JAK2 Exon 12 Mutated Polycythemia Vera: Mayo-Careggi MPN Alliance Study of 33 Consecutive Cases and Comparison With JAK2 V617F Mutated Disease

American Journal of Hematology
Hematology
2018English

Characterization of CD34+ Hematopoietic Progenitor Cells in JAK2 V617F and CALR -Mutated Myeloproliferative Neoplasms

Leukemia Research
Cancer ResearchOncologyHematology
2016English

JAK2-V617F-mediated Signalling Is Dependent on Lipid Rafts and Statins Inhibit JAK2-V617F-dependent Cell Growth

British Journal of Haematology
Hematology
2012English

Kronik Miyeloproliferatif Hastalık Olgularında JAK2 V617F Mutasyon Sıklığı

Harran Üniversitesi Tıp Fakültesi Dergisi
2019English

JAK2 V617F Mutation in Adult T Cell Leukemia-Lymphoma

Indian Journal of Hematology and Blood Transfusion
Hematology
2015English

Screening of JAK2 V617F Mutation in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Evaluation on Thrombotic Events Frequency in JAK2 V617F Positive Patients

Journal of Hematology & Thromboembolic Diseases
2017English

Neuropsychological Signs of Alzheimer's Disease 8 Years Prior to Diagnosis

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2013English

Data‐driven Analysis of JAK2 V617F Kinetics During Interferon‐alpha2 Treatment of Patients With Polycythemia Vera and Related Neoplasms

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy